Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma

Bone Marrow Transplantation

Volumn 36, Issue 11, 2005, Pages 955-961

  Andreadis, C ^a,b   Schuster, S J ^a   Chong, E A ^a   Svoboda, J ^a   Luger, S M ^a   Porter, D L ^a   Tsai, D E ^a   Nasta, S D ^a   Elstrom, R L ^a   Goldstein, S C ^a   Downs, L H ^a   Mangan, P A ^a   Cunningham, K A ^a   Hummel, K A ^a   Gimotty, P A ^b   Siegel, D L ^a   Glatstein, E ^a   Stadtmauer, E A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Autologous stem cell transplantation; Follicular lymphoma; Histologic transformation; Low grade; Total body irradiation

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUDARABINE; MELPHALAN; MITOXANTRONE; RITUXIMAB;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HUMAN; MALE; MALIGNANT TRANSFORMATION; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; SEPSIS; SURVIVAL TIME; WHOLE BODY RADIATION;

ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, FOLLICULAR; LYMPHOMA, LOW-GRADE; MALE; MIDDLE AGED; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 28544447729     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705178     Document Type: Article

References (24)

1. Harris NL, Jaffe ES, Diebold J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835-3849.
2. Sutcliffe SB, Gospodarowicz MK, Bush RS et al. Role of radiation therapy in localized non-Hodgkin's lymphoma. Radiother Oncol 1985; 4: 211-223.
3. Gallagher CJ, Gregory WM, Jones AE et al. Follicular lymphoma: prognostic factors for response and survival. J Clin Oncol 1986; 4: 1470-1480.
4. Acker B, Hoppe RT, Colby TV et al. Histologic conversion in the non-Hodgkin's lymphomas. J Clin Oncol 1983; 1: 11-16.
5. Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med 1984; 311: 1471-1475.
6. Bird JM, Luger S, Mangan P et al. 4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation in non-Hodgkin's lymphoma patients at high risk of bone marrow involvement. Bone Marrow Transplant 1996; 18: 309-313.
7. van Besien K, Loberiza Jr FR, Bajorunaite R et al. Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. Blood 2003; 102: 3521-3529.
8. Stein RS, Greer JP, Goodman S et al. High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin. Bone Marrow Transplant 1999; 23: 227-233.
9. Freedman AS, Neuberg D, Mauch P et al. Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma. Blood 1999; 94: 3325-3333.
10. Apostolidis J, Gupta RK, Grenzelias D et al. High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: Long-term clinical and molecular follow-up. J Clin Oncol 2000; 18: 527-536.
11. Berglund A, Enblad G, Carlson K et al. Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma. Eur J Haematol 2000; 65: 17-22.
12. Cao TM, Horning S, Negrin RS et al. High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: The Stanford University experience. Biol Blood Marrow Transplant 2001; 7: 294-301.
13. Seyfarth B, Kuse R, Sonnen R et al. Autologous stem cell transplantation for follicular lymphoma: No benefit for early transplant? Ann Hematol 2001; 80: 398-405.
14. Schouten HC, Qian W, Kvaloy S et al. High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: Results from the randomized European CUP trial. J Clin Oncol 2003; 21: 3918-3927.
15. Mahe B, Milpied N, Mellerin MP et al. PCR detection of residual Bcl-2/ IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognostic factor for event-free survival in patients with low-grade follicular non-Hodgkin's lymphoma. Bone Marrow Transplant 2003; 31: 467-473.
16. Corradini P, Ladetto M, Zallio F et al. Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: Evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes. J Clin Oncol 2004; 22: 1460-1468.
17. Schouten HC, Bierman PJ, Vaughan WP et al. Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation. Blood 1989; 74: 2579-2584.
18. Bastion Y, Brice P, Haioun C et al. Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood 1995; 86: 3257-3262.
19. Foran JM, Apostolidis J, Papamichael D et al. High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: A study of 27 patients from a single centre. Ann Oncol 1998; 9: 865-869.
20. Chen CI, Crump M, Tsang R et al. Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma. Br J Haematol 2001; 113: 202-208.
21. Williams CD, Harrison CN, Lister TA et al. High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: A case-matched study from the European Bone Marrow Transplant Registry. J Clin Oncol 2001; 19: 727-735.
22. Press OW, Eary JF, Gooley T et al. A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas. Blood 2000; 96: 2934-2942.
23. Vose JM, Bierman PJ, Enke C et al. Phase I trial of iodine-131 tositumomab with high-dose chemotherapy and autologous stem-cell transplantation for relapsed non-Hodgkin's lymphoma. J Clin Oncol 2005; 23: 461-467.
24. Gopal AK, Gooley TA, Maloney DG et al. High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: A multivariable cohort analysis. Blood 2003; 102: 2351-2357.